CTOs on the Move

Apos Therapy

www.apostherapy.com

 
AposTherapy provides a clinically proven, innovative, drug-free, at-home treatment for reducing pain and improving function in patients suffering from knee osteoarthritis and chronic lower back or hip pain.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Apos Therapy raised $11M on 02/17/2020

Similar Companies

Huupe

Founded in 2016, Huupe is the first-ever smart basketball hoop. It brings competition and training to basketball enthusiasts and players, including NBA athletes as well as stars from the league who have invested in the company. Huupe`s groundbreaking innovation enables ages eight and up to compete on the court or virtually, learn and improve their skills, track their progress, and more. The appointment of Paul as CTO follows the company`s 400% growth month over month in the past six months this year, with 50% growth in October 2022 alone, and viral popularity on social media.

Cimex Medical Innovations

Cimex Medical Innovations, L.C. is a Covington, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Boehringer Ingelheim

For more than 130 years, Boehringer Ingelheim has been committed to the research, development, and manufacturing of new medications with high therapeutic value for people and animals. As a family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in research and development. We are proud of addressing some of the most challenging healthcare issues. Our vision – value through innovation – has always characterized our collaborative work, and is for us simultaneously a fundamental requirement and a driving force. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees.

Fairview-University Medical Center

Fairview-University Medical Center is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.